Encapsulating peritoneal sclerosis is associated with T-cell activation

M.G.H. Betjes, Meelad Habib, DG Struijk, DL Barreto, MR Korte, AC Abrahams, Nicole Nagtzaam, Marian Clahsen - van Groningen, Wim Dik, Nicolle Litjens

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)


Encapsulating peritoneal sclerosis (EPS) is an excessive fibrotic response of the peritoneum that may occur after long-term peritoneal dialysis (PD). The underlying pathophysiology is poorly understood, but involvement of peritoneal inflammatory T helper 1 cells may be pivotal. Soluble interleukin-2 receptor alpha (sCD25) concentration was measured as a marker for T-cell activation in serum and ascites from EPS patients and various control patient groups. Peritoneal biopsies were stained for the presence of T cells, and T cells isolated from ascites of EPS patients were characterized in detail for differentiation status and cytokine expression. Serum sCD25 concentrations are significantly and specifically increased in EPS patients compared with haemodialysis, PD and predialysis patients. Peritoneal effluent of stable PD patients contains very low levels of sCD25, while sCD25 levels in ascites of EPS patients are high and indicative of local production. In the years preceding the diagnosis of EPS, the serum sCD25 concentrations increased while remaining at stable levels in control PD patients. The peritoneum and ascites of EPS patients showed a significant influx of T cells with relatively increased numbers of CD4(+) T cells. These T cells were fully differentiated and displayed a T helper 1 cell type with a pro-inflammatory cytokine profile. Increased serum sCD25 concentrations and peritoneal lymphocytosis in EPS patients indicate the involvement of activated T cells in the pathophysiology of excessive fibrosis.
Original languageUndefined/Unknown
Pages (from-to)1568-1576
Number of pages9
JournalNephrology Dialysis Transplantation
Issue number9
Publication statusPublished - 2015

Cite this